Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative Colitis

NCT07686081 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis (UC)

Interventions

DRUG: Ponesimod
DRUG: Placebo

Sponsor

Vanda Pharmaceuticals